NOVOPHARM LTD has a total of 27 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, environmental technology and pharmaceuticals are STAR LAKE BIOSCIENCE CO INC ZHAOQING GUANGDONG, SHANDONG MEDICINAL BIOTECHNOLOGY CT and GENOCLIPP BIOTECHNOLOGY B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Bulgaria | 1 | |
#5 | Brazil | 1 | |
#6 | China | 1 | |
#7 | Czechia | 1 | |
#8 | Estonia | 1 | |
#9 | Finland | 1 | |
#10 | Croatia | 1 | |
#11 | Hungary | 1 | |
#12 | Israel | 1 | |
#13 | Lithuania | 1 | |
#14 | Latvia | 1 | |
#15 | Mexico | 1 | |
#16 | Norway | 1 | |
#17 | New Zealand | 1 | |
#18 | Poland | 1 | |
#19 | Slovakia | 1 | |
#20 | United States | 1 | |
#21 | WIPO (World Intellectual Property Organization) | 1 | |
#22 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Environmental technology | |
#3 | Pharmaceuticals | |
#4 | Organic fine chemistry | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Fermentation | |
#2 | Microorganisms | |
#3 | Climate change adaptation technologies | |
#4 | Therapeutic chemical compounds | |
#5 | Steroids | |
#6 | Unspecified technologies | |
#7 | Microorganisms | |
#8 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Dahiya Jagroop S | 19 |
#2 | Jia Qi | 4 |
#3 | Pamidi Chenchaiah Chinna | 3 |
#4 | Carter John Christopher | 1 |
#5 | Jagroop S Dahiya | 1 |
#6 | Melaku Teshome | 1 |
#7 | Mchugh Michael | 1 |
#8 | Jagroop Singh Dahiya | 1 |
#9 | Pamidi Chenchaiah C | 1 |
Publication | Filing date | Title |
---|---|---|
CA2254411A1 | Ticlopidine hcl formulations | |
EP0983295A2 | 4-aza-steroids substituted in one or more of positions 7, 11 and 15 or with an unsaturated 14(15)-double bond as inhibitors of testosterone-5-alpha-reductase | |
AU5265696A | Fermentation for taxol production | |
NZ245713A | Production of the antibiotic lovastatin from genetically engineered aspergillus strains | |
CA2062023A1 | Novel fungal strains and use thereof in antibiotic production |